Paper795309
Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669.
Rinehart J and 2 others. Am J Trop Med Hyg, 1976. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. Papers, record 795309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/795309
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Phenanthrenes | Major topic |
| Adult | |
| Drug Evaluation | |
| Humans | |
| Male | |
| Middle Aged | |
| Piperidines | |
| Plasmodium falciparum |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32314694 | Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/32314694 | PubMed |
| 28923897 | Controlled Human Malaria Infection: Applications, Advances, and Challenges. | Infect Immun | 2018 | https://conductscience.org/library/papers/28923897 | PubMed |
| 21887214 | A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. | PLoS One | 2011 | https://conductscience.org/library/papers/21887214 | PubMed |
| 9060219 | A clinical trial with halofantrine on patients with falciparum malaria in Colombia. | Bull World Health Organ | 1996 | https://conductscience.org/library/papers/9060219 | PubMed |
| 7955774 | Clinical pharmacokinetics of halofantrine. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7955774 | PubMed |
| 3306266 | Clinical features and management of poisoning due to antimalarial drugs. | Med Toxicol Adverse Drug Exp | 1987 | https://conductscience.org/library/papers/3306266 | PubMed |
| 1372221 | Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential. | Drugs | 1992 | https://conductscience.org/library/papers/1372221 | PubMed |
| 394674 | Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/394674 | PubMed |
| 103492 | Antimalarial activities of WR-194,965, an alpha-amino-o-cresol derivative. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/103492 | PubMed |
| 101132 | Antimalarial activities of various 4-pyridinemethanols with special attention to WR-172,435 and WR-180,409. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/101132 | PubMed |
| 101127 | Antimalarial activities of various 9-phenanthrenemethanols with special attention to WR-122,455 and WR-171,669. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/101127 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/795309
GET https://conductscience.org/api/papers/v1/795309/authors